WHO Approves New Malaria Drug for Infants, Offering Hope for Reduced Child Mortality in Africa
Health

WHO Approves New Malaria Drug for Infants, Offering Hope for Reduced Child Mortality in Africa

The WHO has approved "Coartem Baby," a new malaria treatment for infants in Africa. This development offers hope for reducing child mortality by providing safe and effective treatment options for low-birth-weight and newborn babies who previously had limited therapeutic choices.

This article requires PRO

This article is outside the free access window or is a special report. PRO unlocks it and the full archive.